Skip to main content
BM

BlueWind Medical

BlueWind Medical develops the Revi device, a miniature tibial neuromodulation implant that is placed near the ankle to manage urge urinary incontinence through targeted nerve stimulation. This outpatient procedure offers personalized therapy adjustments, resulting in significant reductions in bladder leaks and high patient satisfaction rates.

London, United KingdomFounded 201011710K+ followers
Updated 20 months ago

Funding

$64M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

C
Funding rounds are not available yet.

Founders

Product

Problem

Urge urinary incontinence (UUI), also known as urgent bladder leaks, significantly impacts quality of life, limiting social activities and causing anxiety due to the unpredictable and frequent need to urinate. Current treatments may not provide sufficient relief or may require ongoing medication and lifestyle adjustments.

Solution

BlueWind Medical's Revi system offers a long-term solution for UUI through a miniature, wirelessly powered neuromodulation implant placed near the ankle. This device delivers targeted tibial nerve stimulation, modulating bladder control signals to reduce the frequency and urgency of urination. The Revi system allows healthcare providers to personalize therapy by adjusting stimulation parameters to optimize individual patient outcomes. Patients can conveniently schedule treatments, integrating therapy into their daily routines without significant disruption.

Target Audience

The primary target audience includes individuals experiencing urge urinary incontinence (UUI) who are seeking a long-term, convenient, and personalized treatment option to reduce bladder leaks and improve their quality of life.

Features

  • Miniature implant placed near the ankle during a single outpatient procedure under local anesthesia
  • Wireless communication between the external controller and the implanted device
  • Personalized therapy adjustments programmable by the healthcare provider
  • Patient-controlled stimulation scheduling for convenient use
  • Demonstrated reduction in urgent bladder leaks, as shown in clinical studies
  • High patient satisfaction rates reported in clinical trials
This profile is AI-generated and may contain inaccuracies.